Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (251-260 of 343) with videos related to

Pageof 35
Sort By:
Journal of Hepatology|November 16, 2023
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinomaTimothy P DiPeri, Ming Zhao, Kurt W Evans, et al.
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With <i>IDH</i>-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
Annals of Surgical Oncology|October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaPat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Cancers|April 23, 2022
Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular CarcinomaGohar Shahwar Manzar, Brian Sandeep De, Chike Osita Abana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract CancersTin-Yun Tang, Federico Nichetti, Ben Kaplan, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
The Lancet. Oncology|August 21, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trialVivek Subbiah, Ulrik Lassen, Elena Élez, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative ChemoradiationSunil Krishnan, Awalpreet S Chadha, Yelin Suh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Occult primary cancer clinical practice guidelinesDavid S Ettinger, Juan P Arnoletti, Jon P Gockerman, et al.
Pageof 35

Showing results (251-260 of 343) with videos related to

Sort By:
Pageof 35
Journal of Hepatology|November 16, 2023
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinomaTimothy P DiPeri, Ming Zhao, Kurt W Evans, et al.
JCO Precision Oncology|February 16, 2022
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With <i>IDH</i>-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase InhibitorsMorten Lapin, Helen J Huang, Sharmeen Chagani, et al.
Annals of Surgical Oncology|October 17, 2018
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaPat Gulhati, Laura Prakash, Matthew H G Katz, et al.
Cancers|April 23, 2022
Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular CarcinomaGohar Shahwar Manzar, Brian Sandeep De, Chike Osita Abana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract CancersTin-Yun Tang, Federico Nichetti, Ben Kaplan, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
The Lancet. Oncology|August 21, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trialVivek Subbiah, Ulrik Lassen, Elena Élez, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative ChemoradiationSunil Krishnan, Awalpreet S Chadha, Yelin Suh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Occult primary cancer clinical practice guidelinesDavid S Ettinger, Juan P Arnoletti, Jon P Gockerman, et al.
Pageof 35